Rxo Inc (RXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 4,550,000 | 3,927,000 | 4,796,000 | 4,689,000 | 3,357,000 |
| Cost of Goods | 3,767,000 | 3,202,000 | 3,850,000 | 3,873,000 | 2,742,000 |
| Gross Profit | 783,000 | 725,000 | 946,000 | 816,000 | 615,000 |
| Operating Expenses | 839,000 | 686,000 | 823,000 | 624,000 | 555,000 |
| Operating Income | -56,000 | 39,000 | 123,000 | 192,000 | 60,000 |
| Interest Expense | 30,000 | 32,000 | 4,000 | 0 | 0 |
| Other Income | -218,000 | -3,000 | 0 | -1,000 | -3,000 |
| Pre-tax Income | -304,000 | 4,000 | 119,000 | 191,000 | 57,000 |
| Income Tax | -14,000 | N/A | 27,000 | 41,000 | 14,000 |
| Net Income Continuous | -290,000 | 4,000 | 92,000 | 150,000 | 43,000 |
| Net Income | $-290,000 | $4,000 | $92,000 | $150,000 | $43,000 |
| EPS Basic Total Ops | -2.17 | 0.03 | 0.80 | 1.30 | 0.37 |
| EPS Basic Continuous Ops | -2.17 | 0.03 | 0.80 | 1.30 | 0.37 |
| EPS Diluted Total Ops | -2.17 | 0.03 | 0.79 | 1.30 | 0.37 |
| EPS Diluted Continuous Ops | -2.17 | 0.03 | 0.79 | 1.30 | 0.37 |
| EPS Diluted Before Non-Recurring Items | 0.12 | 0.30 | 1.56 | N/A | N/A |
| EBITDA(a) | $31,000 | $106,000 | $209,000 | $273,000 | $136,000 |